Beverly Assman
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 5%
- Long-Term Effects of COVID-19
Papers in
-
- HIV/AIDS drug development and treatment 1
-
- Biochemical and Molecular Research 1
- Co-authors
- Reena Shah (1 shared paper)María Fernanda González-Lara (1 shared paper)Ferdinando Lima de Menezes (1 shared paper)Carlos Salama (1 shared paper)William Reiss (1 shared paper)Gerard J. Criner (1 shared paper)Rachel Baden (1 shared paper)Miriam L. Cameron (1 shared paper)
- Journals
- EClinicalMedicine (1 paper)Annals of Clinical and Translational Neurology (1 paper)New England Journal of Medicine (1 paper)Nucleosides Nucleotides & Nucleic Acids (1 paper)
- Partner nations
- United StatesSwitzerlandSpain
In The Last Decade
Beverly Assman
4 papers receiving 832 citations
Beverly Assman's Hit Papers
Peers
Comparison fields: 5 of 87
- Infectious Diseases 503
- Neurology 267
- Critical Care and Intensive Care Medicine 28
- Genetics 42
- Obstetrics and Gynecology 27
Countries citing papers authored by Beverly Assman
This map shows the geographic impact of Beverly Assman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beverly Assman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beverly Assman more than expected).
Fields of papers citing papers by Beverly Assman
This network shows the impact of papers produced by Beverly Assman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beverly Assman. The network helps show where Beverly Assman may publish in the future.
Co-authors
The 25 scholars most cited alongside Beverly Assman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia Hit paper breakdown → | 2020 | 807 |
| 2 | 2022 | 27 | |
| 3 | 2006 | 8 | |
| 4 | 2024 | 5 |
About Beverly Assman
Beverly Assman is a scholar working on Infectious Diseases, Molecular Biology, Genetics, Public Health, Environmental and Occupational Health and Materials Chemistry, having authored 4 papers that have together received 847 indexed citations. Recurring topics across this work include Enzyme Structure and Function (1 paper), HIV/AIDS drug development and treatment (1 paper), Neurogenetic and Muscular Disorders Research (1 paper), Ethics in Clinical Research (1 paper) and Biochemical and Molecular Research (1 paper). The work is most often cited by research in Infectious Diseases (503 citations), Neurology (267 citations), Critical Care and Intensive Care Medicine (28 citations), Genetics (42 citations) and Obstetrics and Gynecology (27 citations). Beverly Assman has collaborated with scholars based in United States, Switzerland and Spain. Frequent co-authors include Reena Shah, María Fernanda González-Lara, Ferdinando Lima de Menezes, Carlos Salama, William Reiss, Gerard J. Criner, Rachel Baden, Miriam L. Cameron, Benjamin Krämer and Emma Kaplan‐Lewis. Their work appears in journals such as EClinicalMedicine, Annals of Clinical and Translational Neurology, New England Journal of Medicine and Nucleosides Nucleotides & Nucleic Acids.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.